New agents can offer a more tailored approach to therapy selection.
Arianne Duong, PharmD, BCOP
Advertisement
Articles by Arianne Duong, PharmD, BCOP
Advertisement
Latest Updated Articles
Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant SettingPublished: October 11th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5
